{"id":10825,"date":"2024-10-08T12:00:28","date_gmt":"2024-10-08T12:00:28","guid":{"rendered":"https:\/\/www.slovensko.ai\/?p=10825"},"modified":"2024-10-05T13:58:41","modified_gmt":"2024-10-05T13:58:41","slug":"hlboke-ucenie-v-objavovani-liekov-a-farmaceutickom-vyskume","status":"publish","type":"post","link":"https:\/\/www.slovensko.ai\/en\/hlboke-ucenie-v-objavovani-liekov-a-farmaceutickom-vyskume\/","title":{"rendered":"Hlbok\u00e9 u\u010denie v objavovan\u00ed liekov a farmaceutickom v\u00fdskume"},"content":{"rendered":"
<\/span> 663<\/span> Viden\u00ed<\/span><\/div>

Hlbok\u00e9 u\u010denie v objavovan\u00ed liekov a farmaceutickom v\u00fdskume<\/strong><\/h2>\n

Objavovanie nov\u00fdch liekov je dlh\u00fd a n\u00e1kladn\u00fd proces, ktor\u00fd \u010dasto trv\u00e1 desa\u0165ro\u010dia a vy\u017eaduje obrovsk\u00e9 invest\u00edcie. Tradi\u010dn\u00e9 met\u00f3dy v\u00fdskumu a v\u00fdvoja liekov s\u00fa zalo\u017een\u00e9 na manu\u00e1lnych experimentoch a laborat\u00f3rnych sk\u00fa\u0161kach, ktor\u00e9 s\u00fa \u010dasovo n\u00e1ro\u010dn\u00e9 a finan\u010dne n\u00e1kladn\u00e9. Hlbok\u00e9 u\u010denie (deep learning), pokro\u010dil\u00fd n\u00e1stroj umelej inteligencie (AI), prin\u00e1\u0161a revol\u00faciu do farmaceutick\u00e9ho v\u00fdskumu t\u00fdm, \u017ee zr\u00fdch\u013euje a zefekt\u00edv\u0148uje tento proces. Vyu\u017eit\u00edm obrovsk\u00fdch s\u00faborov d\u00e1t a schopnosti identifikova\u0165 vzory v zlo\u017eit\u00fdch biologick\u00fdch syst\u00e9moch, deep learning pom\u00e1ha objavova\u0165 nov\u00e9 lieky r\u00fdchlej\u0161ie a presnej\u0161ie.<\/p>\n

Ur\u00fdchlenie procesu objavovania liekov<\/h3>\n

Jedn\u00fdm z najv\u00e4\u010d\u0161\u00edch pr\u00ednosov hlbok\u00e9ho u\u010denia v oblasti farmaceutick\u00e9ho v\u00fdskumu je schopnos\u0165 r\u00fdchlej\u0161ie analyzova\u0165 ve\u013ek\u00e9 mno\u017estvo d\u00e1t. Tradi\u010dn\u00fd proces objavovania liekov zah\u0155\u0148a prechod cez tis\u00edce potenci\u00e1lnych chemick\u00fdch zl\u00fa\u010den\u00edn, aby sa na\u0161li tie, ktor\u00e9 m\u00f4\u017eu ma\u0165 terapeutick\u00fd \u00fa\u010dinok. Tento proces m\u00f4\u017ee trva\u0165 roky. Hlbok\u00e9 u\u010denie v\u0161ak umo\u017e\u0148uje analyzova\u0165 tieto zl\u00fa\u010deniny ove\u013ea r\u00fdchlej\u0161ie, \u010d\u00edm sa skracuje \u010das potrebn\u00fd na identifik\u00e1ciu s\u013eubn\u00fdch kandid\u00e1tov na nov\u00e9 lieky.<\/p>\n

Deep learning modely dok\u00e1\u017eu identifikova\u0165 molekul\u00e1rne \u0161trukt\u00fary, ktor\u00e9 maj\u00fa potenci\u00e1l viaza\u0165 sa na konkr\u00e9tne biologick\u00e9 cie\u013eov\u00e9 miesta, ako s\u00fa prote\u00edny alebo enz\u00fdmy, \u010do je k\u013e\u00fa\u010dov\u00e9 pre \u00fa\u010dinnos\u0165 lie\u010diva. Tieto modely m\u00f4\u017eu takisto simulova\u0165, ako bud\u00fa r\u00f4zne chemick\u00e9 zl\u00fa\u010deniny interagova\u0165 s biologick\u00fdmi syst\u00e9mami, \u010do umo\u017e\u0148uje vedcom predpoveda\u0165 potenci\u00e1lne v\u00fdsledky pred za\u010dat\u00edm laborat\u00f3rnych testov.<\/p>\n

Zni\u017eovanie n\u00e1kladov na v\u00fdvoj liekov<\/h3>\n

Farmaceutick\u00e9 spolo\u010dnosti investuj\u00fa miliardy dol\u00e1rov do v\u00fdvoja nov\u00fdch liekov, pri\u010dom v\u00e4\u010d\u0161ina potenci\u00e1lnych liekov nikdy neprejde cez klinick\u00e9 sk\u00fa\u0161ky. Jedn\u00fdm z d\u00f4vodov s\u00fa vysok\u00e9 n\u00e1klady na v\u00fdskum a v\u00fdvoj, ktor\u00e9 zah\u0155\u0148aj\u00fa po\u010detn\u00e9 testy a overovanie \u00fa\u010dinnosti. Hlbok\u00e9 u\u010denie pom\u00e1ha zn\u00ed\u017ei\u0165 tieto n\u00e1klady t\u00fdm, \u017ee umo\u017e\u0148uje predbe\u017en\u00fa simul\u00e1ciu a anal\u00fdzu liekov e\u0161te predt\u00fdm, ako sa dostan\u00fa do f\u00e1zy klinick\u00fdch sk\u00fa\u0161ok.<\/p>\n

Algoritmy hlbok\u00e9ho u\u010denia m\u00f4\u017eu analyzova\u0165 historick\u00e9 d\u00e1ta z klinick\u00fdch sk\u00fa\u0161ok a identifikova\u0165 faktory, ktor\u00e9 zvy\u0161uj\u00fa pravdepodobnos\u0165 \u00faspechu nov\u00e9ho lieku. To znamen\u00e1, \u017ee farmaceutick\u00e9 spolo\u010dnosti m\u00f4\u017eu lep\u0161ie zamera\u0165 svoje zdroje na s\u013eubn\u00e9 zl\u00fa\u010deniny, \u010d\u00edm sa minimalizuje riziko finan\u010dn\u00fdch str\u00e1t a zr\u00fdchli sa proces v\u00fdvoja.<\/p>\n

Presnej\u0161ie predpovede \u00fa\u010dinnosti liekov<\/h3>\n

Hlbok\u00e9 u\u010denie umo\u017e\u0148uje vytv\u00e1ra\u0165 sofistikovan\u00e9 predikt\u00edvne modely, ktor\u00e9 dok\u00e1\u017eu presnej\u0161ie odhadn\u00fa\u0165 \u00fa\u010dinnos\u0165 nov\u00fdch liekov na z\u00e1klade ich molekul\u00e1rnej \u0161trukt\u00fary a sp\u00f4sobu interakcie s cie\u013eov\u00fdmi prote\u00ednmi. To znamen\u00e1, \u017ee vedci m\u00f4\u017eu v ranom \u0161t\u00e1diu v\u00fdvoja eliminova\u0165 zl\u00fa\u010deniny, ktor\u00e9 by mohli by\u0165 ne\u00fa\u010dinn\u00e9 alebo nebezpe\u010dn\u00e9.<\/p>\n

Tieto predikt\u00edvne modely m\u00f4\u017eu takisto odhali\u0165 neo\u010dak\u00e1van\u00e9 terapeutick\u00e9 \u00fa\u010dinky liekov, \u010do umo\u017e\u0148uje farmaceutick\u00fdm firm\u00e1m objavi\u0165 nov\u00e9 mo\u017enosti vyu\u017eitia existuj\u00facich liekov. Napr\u00edklad lieky, ktor\u00e9 p\u00f4vodne neuspeli v sk\u00fa\u0161kach na lie\u010dbu jednej choroby, m\u00f4\u017eu by\u0165 \u00faspe\u0161ne vyu\u017eit\u00e9 na lie\u010dbu in\u00fdch zdravotn\u00fdch stavov, \u010do v\u00fdrazne ur\u00fdch\u013euje proces v\u00fdvoja.<\/p>\n

Personalizovan\u00e1 medic\u00edna a predikcia ved\u013eaj\u0161\u00edch \u00fa\u010dinkov<\/h3>\n

Jedn\u00fdm z najd\u00f4le\u017eitej\u0161\u00edch pr\u00edspevkov AI a hlbok\u00e9ho u\u010denia je potenci\u00e1l v oblasti personalizovanej medic\u00edny. Ka\u017ed\u00fd pacient reaguje na lie\u010dbu inak v z\u00e1vislosti od svojho genetick\u00e9ho zlo\u017eenia, \u017eivotn\u00e9ho \u0161t\u00fdlu a \u010fal\u0161\u00edch faktorov. Hlbok\u00e9 u\u010denie dok\u00e1\u017ee analyzova\u0165 genetick\u00e9 a zdravotn\u00e9 \u00fadaje jednotlivcov a predpoveda\u0165, ktor\u00e9 lieky bud\u00fa pre nich naj\u00fa\u010dinnej\u0161ie a z\u00e1rove\u0148 najmenej rizikov\u00e9. Vyu\u017eitie AI v diagnostike<\/strong> pom\u00e1ha pri personaliz\u00e1cii lie\u010dby, ke\u010f\u017ee presnej\u0161ie ur\u010duje potreby pacientov.<\/p>\n

Tento pr\u00edstup m\u00f4\u017ee minimalizova\u0165 ved\u013eaj\u0161ie \u00fa\u010dinky a zv\u00fd\u0161i\u0165 \u00faspe\u0161nos\u0165 lie\u010dby. Napr\u00edklad, algoritmy hlbok\u00e9ho u\u010denia m\u00f4\u017eu identifikova\u0165 pacientov, ktor\u00ed s\u00fa n\u00e1chyln\u00ed na negat\u00edvne reakcie na konkr\u00e9tne lieky, a navrhn\u00fa\u0165 alternat\u00edvne mo\u017enosti lie\u010dby. To m\u00f4\u017ee v\u00fdrazne zlep\u0161i\u0165 kvalitu zdravotnej starostlivosti a zn\u00ed\u017ei\u0165 n\u00e1klady na lie\u010dbu komplik\u00e1ci\u00ed sp\u00f4soben\u00fdch nespr\u00e1vne zvolen\u00fdmi liekmi.<\/p>\n

Optimaliz\u00e1cia klinick\u00fdch sk\u00fa\u0161ok<\/h3>\n

Klinick\u00e9 sk\u00fa\u0161ky s\u00fa jednou z najdrah\u0161\u00edch f\u00e1z v\u00fdvoja liekov. V\u00fdber spr\u00e1vnych pacientov na klinick\u00e9 sk\u00fa\u0161ky, monitorovanie v\u00fdsledkov a anal\u00fdza \u00fadajov je \u010dasovo aj finan\u010dne n\u00e1ro\u010dn\u00e1 \u00faloha. Hlbok\u00e9 u\u010denie m\u00f4\u017ee pom\u00f4c\u0165 optimalizova\u0165 tento proces t\u00fdm, \u017ee dok\u00e1\u017ee presne identifikova\u0165 najvhodnej\u0161\u00edch pacientov na z\u00e1klade ich genetick\u00fdch profilov a predpokladan\u00fdch reakci\u00ed na lieky.<\/p>\n

AI tie\u017e umo\u017e\u0148uje sledovanie priebehu klinick\u00fdch sk\u00fa\u0161ok v re\u00e1lnom \u010dase a poskytuje vedcom okam\u017eit\u00fa sp\u00e4tn\u00fa v\u00e4zbu, \u010do im umo\u017e\u0148uje r\u00fdchlej\u0161ie prisp\u00f4sobova\u0165 svoje strat\u00e9gie. T\u00fdmto sp\u00f4sobom m\u00f4\u017eu by\u0165 klinick\u00e9 sk\u00fa\u0161ky efekt\u00edvnej\u0161ie a lacnej\u0161ie, \u010do vedie k r\u00fdchlej\u0161iemu uvedeniu nov\u00fdch liekov na trh.<\/p>\n

Elektronick\u00e9 zdravotn\u00edctvo a AI<\/h3>\n

S n\u00e1stupom elektronick\u00e9ho zdravotn\u00edctva a AI sa otv\u00e1raj\u00fa nov\u00e9 mo\u017enosti pre optimaliz\u00e1ciu zdravotnej starostlivosti a lie\u010dby pacientov. Elektronick\u00e9 zdravotn\u00edctvo umo\u017e\u0148uje zhroma\u017e\u010fovanie a anal\u00fdzu d\u00e1t v re\u00e1lnom \u010dase, \u010d\u00edm sa zvy\u0161uje efektivita lie\u010dby. Hlbok\u00e9 u\u010denie m\u00f4\u017ee poskytn\u00fa\u0165 cenn\u00e9 n\u00e1stroje pre monitorovanie zdravia pacientov a identifik\u00e1ciu optim\u00e1lnych terapeutick\u00fdch pr\u00edstupov.<\/p>\n

Z\u00e1ver<\/h3>\n

Hlbok\u00e9 u\u010denie prin\u00e1\u0161a revolu\u010dn\u00e9 zmeny do procesu objavovania liekov a farmaceutick\u00e9ho v\u00fdskumu. Umo\u017e\u0148uje zr\u00fdchli\u0165 proces v\u00fdvoja, zni\u017eova\u0165 n\u00e1klady a zvy\u0161ova\u0165 presnos\u0165 predpoved\u00ed \u00fa\u010dinnosti a bezpe\u010dnosti liekov. T\u00e1to technol\u00f3gia nielen \u017ee otv\u00e1ra nov\u00e9 mo\u017enosti v oblasti personalizovanej medic\u00edny, ale tie\u017e optimalizuje klinick\u00e9 sk\u00fa\u0161ky a zlep\u0161uje celkov\u00fa efektivitu farmaceutick\u00e9ho priemyslu. Vyu\u017eitie AI a hlbok\u00e9ho u\u010denia m\u00e1 potenci\u00e1l z\u00e1sadne zmeni\u0165 sp\u00f4sob, ak\u00fdm lieky vznikaj\u00fa, \u010d\u00edm prispeje k zlep\u0161eniu zdravotnej starostlivosti na celom svete.<\/p>","protected":false},"excerpt":{"rendered":"

663 Viden\u00edHlbok\u00e9 u\u010denie v objavovan\u00ed liekov a farmaceutickom v\u00fdskume Objavovanie nov\u00fdch liekov je dlh\u00fd a n\u00e1kladn\u00fd proces, ktor\u00fd \u010dasto trv\u00e1 desa\u0165ro\u010dia a vy\u017eaduje obrovsk\u00e9 invest\u00edcie. Tradi\u010dn\u00e9 met\u00f3dy v\u00fdskumu a v\u00fdvoja liekov s\u00fa zalo\u017een\u00e9 na manu\u00e1lnych experimentoch a laborat\u00f3rnych sk\u00fa\u0161kach, ktor\u00e9 s\u00fa \u010dasovo n\u00e1ro\u010dn\u00e9 a finan\u010dne n\u00e1kladn\u00e9. Hlbok\u00e9 u\u010denie (deep learning), pokro\u010dil\u00fd n\u00e1stroj umelej inteligencie (AI), […]<\/p>\n","protected":false},"author":51,"featured_media":10826,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[51,329],"tags":[77,53,221],"class_list":["post-10825","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-umela-inteligencia","tag-ai","tag-umela-inteligencia","tag-umela-inteligencia-v-medicine"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/posts\/10825"}],"collection":[{"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/users\/51"}],"replies":[{"embeddable":true,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/comments?post=10825"}],"version-history":[{"count":1,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/posts\/10825\/revisions"}],"predecessor-version":[{"id":10827,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/posts\/10825\/revisions\/10827"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/media\/10826"}],"wp:attachment":[{"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/media?parent=10825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/categories?post=10825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.slovensko.ai\/en\/wp-json\/wp\/v2\/tags?post=10825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}